Co-diagnostics, inc. to ceo to deliver keynote address at 2023 marketsandmarkets conference in london, england

Salt lake city , march 21, 2023 /prnewswire/ -- co-diagnostics, inc. (nasdaq: codx) (the "company" or "co-dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that the company ceo will deliver the keynote address at the 4th annual marketsandmarkets infectious disease diagnostics and molecular diagnostics conference, held march 23-24, 2023, in london, england, where the company will also be hosting a booth. dwight egan, ceo of co-diagnostics, will be delivering the keynote presentation on the company's upcoming co-dx pcr home™ testing platform at 9:10 am local time on march 23.
CODX Ratings Summary
CODX Quant Ranking